NuCana plc
NUC-7738
melanoma
Date
TBD
FDA decision · Date TBD estimated
What's at stake
An FDA complete response letter on NUC-7738 for melanoma is in focus around Date TBD.
Primary source
· SEC 6-K
verified 12h ago
“We look forward to advancing our dialogue with the FDA to determine the optimal pathway toward a potential registrational strategy for NUC-7738 in melanoma.”